220 related articles for article (PubMed ID: 26239109)
1. In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin.
Stellari F; Bergamini G; Sandri A; Donofrio G; Sorio C; Ruscitti F; Villetti G; Assael BM; Melotti P; Lleo MM
J Transl Med; 2015 Aug; 13():251. PubMed ID: 26239109
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
Li Y; Huang J; Li L; Liu L
Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
5. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL
Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
Hoffmann N; Lee B; Hentzer M; Rasmussen TB; Song Z; Johansen HK; Givskov M; Høiby N
Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
[TBL] [Abstract][Full Text] [Related]
8. In vivo monitoring of lung inflammation in CFTR-deficient mice.
Stellari F; Bergamini G; Ruscitti F; Sandri A; Ravanetti F; Donofrio G; Boschi F; Villetti G; Sorio C; Assael BM; Melotti P; Lleo MM
J Transl Med; 2016 Jul; 14(1):226. PubMed ID: 27468800
[TBL] [Abstract][Full Text] [Related]
9. An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses.
Bergamini G; Stellari F; Sandri A; M Lleo M; Donofrio G; Ruscitti F; Boschi F; Sbarbati A; Villetti G; Melotti P; Sorio C
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28715404
[TBL] [Abstract][Full Text] [Related]
10. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
Reinert P
Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin Modulates 3',5'-cyclic Diguanylic Acid Signaling in Pseudomonas aeruginosa.
Kimura S; Mori N; Kai T; Ishii Y; Yamaguchi K; Tateda K
J Infect Chemother; 2017 Aug; 23(8):550-555. PubMed ID: 28579350
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
[TBL] [Abstract][Full Text] [Related]
13. Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia.
Kikuchi Y; Tateda K; Fuse ET; Matsumoto T; Gotoh N; Fukushima J; Takizawa H; Nagase T; Standiford TJ; Yamaguchi K
Pulm Pharmacol Ther; 2009 Aug; 22(4):333-9. PubMed ID: 19162211
[TBL] [Abstract][Full Text] [Related]
14. PA5470 Counteracts Antimicrobial Effect of Azithromycin by Releasing Stalled Ribosome in Pseudomonas aeruginosa.
Shi J; Liu Y; Zhang Y; Jin Y; Bai F; Cheng Z; Jin S; Wu W
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203495
[No Abstract] [Full Text] [Related]
15. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection.
Halldorsson S; Gudjonsson T; Gottfredsson M; Singh PK; Gudmundsson GH; Baldursson O
Am J Respir Cell Mol Biol; 2010 Jan; 42(1):62-8. PubMed ID: 19372247
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa.
Saini H; Vadekeetil A; Chhibber S; Harjai K
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194
[No Abstract] [Full Text] [Related]
18. Baicalein attenuates the quorum sensing-controlled virulence factors of Pseudomonas aeruginosa and relieves the inflammatory response in P. aeruginosa-infected macrophages by downregulating the MAPK and NFκB signal-transduction pathways.
Luo J; Kong JL; Dong BY; Huang H; Wang K; Wu LH; Hou CC; Liang Y; Li B; Chen YQ
Drug Des Devel Ther; 2016; 10():183-203. PubMed ID: 26792984
[TBL] [Abstract][Full Text] [Related]
19. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.
Le Berre R; Nguyen S; Nowak E; Kipnis E; Pierre M; Quenee L; Ader F; Lancel S; Courcol R; Guery BP; Faure K;
Crit Care Med; 2011 Sep; 39(9):2113-20. PubMed ID: 21572326
[TBL] [Abstract][Full Text] [Related]
20. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
